研究等業績 - その他 - 田口　大樹

Role of clonal lineage analysis via next-generation sequencing in identifying the origin of multiple cancers and guiding treatment options

Shimoyachi R.

Japanese Journal of Clinical Oncology ( Japanese Journal of Clinical Oncology )  56 ( 4 ) 489 - 495   2026年04月

DOI

Familial adenomatous polyposis family with clustering of psychiatric disorders

Funaki M.

Japanese Journal of Clinical Oncology ( Japanese Journal of Clinical Oncology )  55 ( 4 ) 435 - 439   2025年04月

DOI

Administration of Nivolumab plus FOLFOX Therapy to a Patient with Gastric Cancer Undergoing Hemodialysis: A Case Report

Yoshida Taichi, Kodama Naoaki, Matsumoto Tomohiro, Taguchi Daiki, Shimazu Kazuhiro, Fukuda Koji, Shibata Hiroyuki

Internal Medicine ( 一般社団法人 日本内科学会 )  advpub ( 0 ) 1205 - 1209   2025年

<p>The optimal dose of chemotherapy for patients undergoing hemodialysis remains unclear. A 65-year-old man with diabetic nephropathy was treated with nivolumab plus modified FOLFOX6 therapy for recurrent gastric cancer with liver metastases. Oxaliplatin was reduced to 65 mg/m², continuous infusion of 5-fluorouracil was initiated at 2,000 mg/m², and bolus administration was discontinued. No nivolumab was administrated. Dose modification and discontinuation were performed depending on the patient's general condition and blood test during the treatment course. He received standard chemotherapy for gastric cancer; however, it was ineffective because of ascites and elevated CA125 levels. </p>

DOI PubMed CiNii Research

Association between albumin–bilirubin grade and plasma trough concentrations of regorafenib and its metabolites M-2 and M-5 at steady-state in Japanese patients

Fujita K.

Investigational New Drugs ( Investigational New Drugs )  42 ( 3 ) 252 - 260   2024年06月

DOI

Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs^∗48 variant for platinum-based drug and PARP inhibitor

Akahira R.

Japanese Journal of Clinical Oncology ( Japanese Journal of Clinical Oncology )  54 ( 2 ) 201 - 205   2024年02月

DOI

Clinical Course of a Rare Epstein-Barr Virus-Associated Smooth Muscle Tumor and Its Genomic Analysis

Miyahara J.

Case Reports in Oncology ( Case Reports in Oncology )  16 ( 1 ) 577 - 584   2023年08月

DOI

Lymph-node metastasis from gastric adenocarcinoma in a patient bearing a germ line missense variant MSH2 c.1808A &gt; T (Asp603Val) responds to the immune checkpoint inhibitor pembrolizumab

Kiyomiya M.

Japanese journal of clinical oncology ( Japanese journal of clinical oncology )  53 ( 3 ) 270 - 274   2023年03月

DOI

Pulmonary Artery Intimal Sarcoma in a Patient with Lynch Syndrome: Response to an Immune Checkpoint Inhibitor

Mounai Y.

Case Reports in Oncology ( Case Reports in Oncology )  16 ( 1 ) 21 - 29   2023年

DOI

A novel Lynch syndrome pedigree bearing germ-line MSH2 missense mutation c.1808A&gt;T (Asp603Val)

Sekine R.

Japanese Journal of Clinical Oncology ( Japanese Journal of Clinical Oncology )  52 ( 1 ) 81 - 85   2022年01月

DOI

Two Cases of ALK-Altered Cancers of Unknown Primary Diagnosed by Immunohistochemistry

Kato Y.

Case Reports in Oncology ( Case Reports in Oncology )  15 ( 1 ) 21 - 26   2022年01月

DOI

The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells

MaruYama T.

Frontiers in Immunology ( Frontiers in Immunology )  12   2021年06月

DOI

Clinical efficacy and safety of second line and salvage aflibercept for advanced colorectal cancer in Akita prefecture

Yoshida T.

World Journal of Gastrointestinal Oncology ( World Journal of Gastrointestinal Oncology )  13 ( 4 ) 295 - 304   2021年

DOI

Outcome of colorectal cancer in Diamond–Blackfan syndrome with a ribosomal protein S19 mutation

Kimura K.

Clinical Journal of Gastroenterology ( Clinical Journal of Gastroenterology )  13 ( 6 ) 1173 - 1177   2020年12月

DOI

Lung adenocarcinoma in a patient with Li-Fraumeni syndrome bearing a novel germ-line mutation, TP53R333Vfs^∗12

Takahashi S.

Japanese Journal of Clinical Oncology ( Japanese Journal of Clinical Oncology )  50 ( 10 ) 1214 - 1217   2020年10月

DOI

Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities

Taguchi D.

International Journal of Clinical Oncology ( International Journal of Clinical Oncology )  25 ( 4 ) 531 - 540   2020年04月

DOI

Dietary intake of pyrolyzed deketene curcumin inhibits gastric carcinogenesis

Yoshida T.

Journal of Functional Foods ( Journal of Functional Foods )  50   192 - 200   2018年11月

DOI

Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors

Shimazu K.

Cancer Science ( Cancer Science )  109 ( 10 ) 3285 - 3293   2018年10月

DOI

Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution

Yoshida T.

International Journal of Clinical Oncology ( International Journal of Clinical Oncology )  22 ( 2 ) 244 - 249   2017年04月

DOI